Publications by authors named "Haopeng Sun"

Claim this Profile
S
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics.
Xiaolong Wang, Can Guo, Jikuan Shao, Xinyu Zou, Shuaishuai Xing, Chengliang Sun, Haopeng Sun

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-Life Famine Exposure, Financial Literacy, and Retirement Planning: Evidence from China.
Haopeng Sun, Yuanhua Xu

Int J Aging Hum Dev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomics accelerates drug development and facilitates the discovery of new targets, mechanisms and structures.
Yu Zhou, Ziwei Xu, Baichen Xiong, Zuoaoyun Song, Leyan Wang, Haopeng Sun

Bioorg Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging and anti-aging strategies: A review of past and future therapeutics.
Yuqing Wei, Baichen Xiong, Zuoaoyun Song, Sheng Zhong, Na Zheng, Haopeng Sun

Bioorg Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief analysis of Na1.7 inhibitors: Mechanism of action and new research trends.
Zhoujun Dong, Baichen Xiong, Tianyu Sun, Ruijia Jiang, Feng Feng, Haopeng Sun

Bioorg Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease.
Urban Košak, Damijan Knez, Svit Ferjančič Benetik, Peter Mastnak Sokolov, Anja Pišlar, Haopeng Sun

Chem Biol Interact· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Selective Inhibitors of SMARCA2 ATPase Domain by Virtual Screening and Biological Evaluation.
Jiawei Zhu, Xiaoxue Bai, Yucheng Xiong, Chenlong Xie, Yao Chen, Haopeng Sun

ACS Med Chem Lett· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.
Bingbing Lv, Zhenqi Wang, Qinjie Wang, Zhaoxin Xu, Jixiong Tang, Haopeng Sun

Bioorg Med Chem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC6/Trim21 aggravates macrophage inflammatory response and titanium-induced osteolysis via GSDMD signaling pathway.
Junxi Chen, Taihe Liu, Jiankai Luo, Zhipeng Chen, Yifan Yu, Haopeng Sun, Yujun Sun

J Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease.
Anže Meden, Neža Žnidaršič, Damijan Knez, Yuanyuan Wang, Ziwei Xu, Haopeng Sun

Acta Pharm Sin B· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
Urban Košak, Nika Strašek Benedik, Damijan Knez, Simon Žakelj, Jurij Trontelj, Haopeng Sun

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future.
Yuanyuan Wang, Ruijia Jiang, Baichen Xiong, Jiawei Zhu, Jingjing Sang, Haopeng Sun

Drug Dev Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance.
Shuaishuai Xing, Yijun Liu, Huanfang Xie, Can Guo, Xiaolong Wang, Haopeng Sun

Eur J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma.
Shuaishuai Xing, Jiheng Jiang, Xianglin Chu, Xiaolong Wang, Zhiqiang Wang, Haopeng Sun

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease.
Xiaoxue Bai, Jiawei Zhu, Yao Chen, Haopeng Sun

Future Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRF2 inhibitors: Recent progress, future design and therapeutic potential.
Bingbing Lv, Shuaishuai Xing, Zhiqiang Wang, Ao Zhang, Qinjie Wang, Haopeng Sun

Eur J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical control of butyrylcholinesterase (BChE) activity via photoswitchable azobenzene for potential treatment of Alzheimer's disease.
Lei Wang, Ziming Gao, Tianyu Sun, Chen Chen, Jiawei Zhu, Haopeng Sun

Bioorg Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherent Temporal Metamaterials with Unique Time-Varying Stiffness and Damping.
Zhiyuan Liu, Kaijun Yi, Haopeng Sun, Rui Zhu, Xiaoming Zhou

Adv Sci (Weinh)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.
Meiyang Xi, Jingjing Zhu, Fengxia Zhang, Hualiang Shen, Jianhui Chen, Haopeng Sun

Eur J Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?
Baichen Xiong, Zuoaoyun Song, Leyan Wang, Ao Zhang, Yu Zhou, Haopeng Sun

ACS Chem Neurosci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight into targeting the DNA damage response in the treatment of glioblastoma.
Tengfei Zhen, Tianyu Sun, Baichen Xiong, Hui Liu, Lei Wang, Haopeng Sun

Chin J Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands.
Tianyu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, Lei Wang, Huanchao Guo, Haopeng Sun

Eur J Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural modification strategies of triazoles in anticancer drug development.
Qianwen Guan, Ziming Gao, Yuting Chen, Can Guo, Yao Chen, Haopeng Sun

Eur J Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and optimization of nitrophenolic analogues as dopamine metabolic enzyme inhibitors for the treatment of Parkinson's disease.
Manxing Zou, Yulu Wu, Yudan Lan, Huanfang Xie, Haopeng Sun

Bioorg Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
Yuqing Wei, Sheng Zhong, Huajing Yang, Xueqing Wang, Bingbing Lv, Haopeng Sun

Eur J Med Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis